Orchidectomy versus buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843
- 20 December 1990
- journal article
- clinical trial
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (6) , 965-969
- https://doi.org/10.1016/0960-0760(90)90451-p
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Orchidectomy versus Zoladex® plus Eulexin® in patients with metastatic prostate cancer (EORTC 30853)The Journal of Steroid Biochemistry and Molecular Biology, 1990
- Treatment of newly diagnosed state D2 prostate cancer with leuprolide and flutamide or leuprolide alone, phase III, intergroup study 0036The Journal of Steroid Biochemistry and Molecular Biology, 1990
- The EORTC studies: is there an optimal endocrine management for M1 prostatic cancer?World Journal of Urology, 1986
- A Comparison of the Effect of Diethylstilbestrol with Low Dose Estramustine Phosphate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Phase III Trial of the European Organization for Research on Treatment of CancerJournal of Urology, 1986
- Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urological GroupJournal of Urology, 1986
- COMBINED TREATMENT WITH BUSEREUN AND CYPROTERONE ACETATE IN METASTATIC PROSTATIC CARCINOMAThe Lancet, 1985
- Langzeitsuppression der gonadalen Testosteronproduktion durch den LH-RH-Agonisten (Buserelinacetat; Hoe 766) beim fortgeschrittenen Prostatakarzinom - eine neue Therapieform?Aktuelle Urologie, 1982